文献速递衰弱、肌少症与跌倒老年慢病共病管理

抑郁症状变化与肌少症风险的全国队列关联研究

Association Between Changes in Depressive Symptoms and Sarcopenia: Findings From a Nationwide Cohort Study.
PubMed 文献 · J Am Med Dir Assoc · 2023-07-27

该研究基于中国健康与养老追踪调查(CHARLS)数据,横断面分析纳入12287名参与者,纵向分析纳入5285名参与者,每2年重复测量抑郁症状(CES-D-10),肌少症按AWGS 2019标准定义。横断面分析显示抑郁与肌少症显著相关(OR 1.27,95%CI 1.10-1.48);纵向分析中174例新发肌少症,抑郁症状增加者和持续抑郁者肌少症风险分别升高(HR 1.65,95%CI 1.00-2.73;HR 1.68,95%CI 1.06-2.68)。

要点

  • 横断面分析中抑郁症状与肌少症显著相关(OR 1.27,95%CI 1.10-1.48)。
  • 纵向分析中抑郁症状增加者肌少症风险升高(HR 1.65,95%CI 1.00-2.73)。
  • 持续抑郁症状者肌少症风险亦升高(HR 1.68,95%CI 1.06-2.68)。

核心结论

  • 抑郁症状增加或持续存在的人群随时间推移发生肌少症的风险可能更高。

研究设计与样本

  • 基于中国健康与养老追踪调查(CHARLS)的横断面与纵向研究,横断面分析纳入12287名参与者(2011-2012年),纵向分析纳入5285名参与者(2013-2014年及2015-2016年)。

主要发现

  • 横断面分析中抑郁与肌少症显著相关(OR 1.27,95%CI 1.10-1.48)。
  • 纵向分析共发生174例肌少症事件,抑郁症状增加者较无抑郁症状者肌少症风险升高(多变量校正HR 1.65,95%CI 1.00-2.73)。
  • 持续抑郁症状者较无抑郁症状者肌少症风险亦升高(多变量校正HR 1.68,95%CI 1.06-2.68)。

关键数值与推荐

  • 抑郁症状采用10项流行病学研究中心抑郁量表简版(CES-D-10)测量。
  • 肌少症依据亚洲肌少症工作组2019标准(AWGS 2019)定义。
  • 暴露为第1波和第2波抑郁症状变化,结局为第3波肌少症,采用Cox比例风险回归模型分析。

临床怎么用

  • 对老年患者应重复评估抑郁症状变化,抑郁症状加重或持续存在者需关注肌少症风险。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to investigate the association between changes in depressive symptoms and sarcopenia by repeated measures of depressive symptoms at a follow-up visit every 2 years. DESIGN: Cross-sectional design and longitudinal design. SETTING AND PARTICIPANTS: We conducted a cross-sectional and longitudinal study using data from the China Health and Retirement Longitudinal Study, which is a representative national survey. A total of 12,287 participants were included in Wave 1 (2011-2012) for the cross-sectional analysis, followed by a total of 5285 participants in Wave 2 (2013-2014) and Wave 3 (2015-2016) for the longitudinal analysis based on the cross-sectional analysis. METHODS: Depressive symptoms were measured by the 10-item Center for the Epidemiological Studies of Depression Short Form. Sarcopenia was defined according to the Asian Sarcopenia Working Group criteria (AWGS 2019). Changes in depressive symptoms in Wave 1 and Wave 2 were used as exposure, and sarcopenia in Wave 3 was used as outcome. Cox proportional hazards regression model was used to test the relationship between changes in depressive symptoms and sarcopenia. RESULTS: In cross-sectional analysis, depression was significantly associated with sarcopenia (odds ratio, 1.27; 95% CI, 1.10-1.48). In subsequent longitudinal analyses, a total of 174 sarcopenia events occurred, and those with increased depressive symptoms and persistent depressive symptoms were at higher risk for sarcopenia than those without depressive symptoms, with multivariable-adjusted hazard ratios of 1.65 (95% CI, 1.00-2.73) and 1.68 (95% CI, 1.06-2.68), respectively. CONCLUSIONS AND IMPLICATIONS: People with increased depressive symptoms and persistent depressive symptoms may have a higher risk of developing sarcopenia over time. In the future, more research is needed to confirm the mechanism by which long-term changes in depression contribute to the risk of sarcopenia, and to propose preventive measures accordingly.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Han L, Jiang M, Ren X, et al. Association Between Changes in Depressive Symptoms and Sarcopenia: Findings From a Nationwide Cohort Study. J Am Med Dir Assoc. 2023. PMID: 37516438. doi:10.1016/j.jamda.2023.06.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。